Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Bio-Rad Laboratories (BIO) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Bio-Rad Laboratories is a member of the Medical sector. This group includes 1013 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank considers 16 different gro ...

Corporate presentation scheduled for Tuesday, February 11, 2025 at 10:15 AM ESTCARMIEL, Israel, Feb. 4, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell based protein expression system, today announced that it will attend and present at the 2025 BIO CEO & Investor Conference taking place February 10-11, 2025 at ...

CHASKA, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 2025 BIO CEO & Investor Conference. The conference will take place February 10-11, 2025, in New York, NY. Details regarding Lifecore’s participation are as follows: 2025 BIO CEO & Investor ConferenceDetails: Lifecore management, including Paul Josephs, chief executive o ...

Bio-Rad Laboratories, Inc.’s (BIO) solid momentum in the QX600 Droplet Digital PCR (ddPCR) platform is poised to help it grow in the upcoming quarters. The clinical diagnostics business sees increased demand for quality control products, boosting its growth. Furthermore, the company’s emphasis on international expansion bodes well.  Yet, a soft Biopharma segment and macro-driven pressures on Bio-Rad’s margins raise worries.In the past year, shares of this Zacks Rank #2 (Buy) company have soared 13.3% compar ...

文章核心观点 Bio - Techne公司将在Phacilitate的先进疗法周展示其支持细胞和基因疗法开发与制造的创新产品和解决方案，包括ProPak™ GMP细胞因子等，公司科学家还将进行相关演讲和产品演示 [1][2][3] 公司展示信息 - 公司将在1月20 - 23日于德克萨斯州达拉斯的Kay Bailey Hutchison会议中心举行的Phacilitate先进疗法周展示新的ProPak™ GMP细胞因子及创新产品和解决方案 [1] - 公司将在517号展位展示细胞和基因疗法工作流程的可重复性和可扩展性解决方案，包括高质量试剂和分析技术组合，亮点有ProPak液体GMP细胞因子、Ella™自动ELISA平台及其Simple Plex™检测等 [2] 公司人员活动 - 公司首席科学家David Hermanson博士将于1月21日下午12:15进行关于封闭系统制造的分组讨论，聚焦细胞疗法项目各阶段确保灵活性和可扩展性的策略及选择制造平台需考虑的因素 [3][6] - David Hermanson博士还将于1月22日上午10:00在创新区进行产品演示，强调ProPak细胞因子集成到T细胞制造工作流程的情况及采用封闭系统解决方案的优势 [4][7] 公司相关表态 - 公司蛋白质科学部门总裁Will Geist表示公司致力于高效制造救生细胞和基因修饰细胞疗法，ProPak GMP细胞因子能为CAR - T和TCR - T细胞药物产品的封闭系统扩增提供精确数量的细胞因子，公司期待展示全套细胞和基因疗法工作流程解决方案 [5] 公司基本情况 - Bio - Techne是一家全球生命科学公司，为研究和临床诊断界提供创新工具和生物活性试剂，产品助力生物过程研究、疾病诊断和药物发现，2024财年净销售额约12亿美元，全球约有3100名员工 [8] ScaleReady相关情况 - ScaleReady为细胞和基因修饰细胞疗法领域提供以G - Rex为中心的制造平台，该平台被超800个组织使用，为约50%的细胞和基因疗法临床试验及5种商业批准的细胞和基因疗法药物生产产品 [10] - 依赖ScaleReady专业知识的细胞和基因疗法实体有望在商业化道路上节省数年时间和数百万美元 [11]

文章核心观点 Bio - Techne与MedSanTek达成合作，MedSanTek将在土耳其分销Bio - Techne旗下多个品牌产品，双方期望借此拓展市场并推动科学和医学进步 [1][3] 合作信息 - Bio - Techne宣布与MedSanTek达成合作，MedSanTek成为Bio - Techne旗下R&D Systems、Novus等品牌在土耳其的分销商 [1] 合作方情况 MedSanTek - 成立于2000年代末，是领先的体外诊断和研究产品分销商，服务于土耳其和阿塞拜疆 [2] - 与全球品牌合作，在分子生物学、免疫学等领域提供高质量解决方案，以创新和客户满意度著称 [2] Bio - Techne - 是全球生命科学公司，为研究和临床诊断领域提供创新工具和生物活性试剂 [1][4] - 产品助力生物过程研究、疾病研究、药物发现及临床检测诊断 [4] - 2024财年净销售额约12亿美元，全球约有3100名员工 [4] 合作双方表态 MedSanTek - 创始人兼总经理Mr İbrahim Selçuk表示很高兴合作，将把Bio - Techne产品带给土耳其和阿塞拜疆的生物科技公司、实验室和医院 [3] - 称自成立以来以质量、及时交付和强大客户支持著称，有专业团队和主要城市网络，致力于共同成功和推动科研 [3] Bio - Techne - 欧洲、中东和非洲地区副总裁兼总经理Dr. Peter Schüßler称很高兴合作，以拓展在土耳其和阿塞拜疆市场的产品和服务覆盖范围 [3] - 认为MedSanTek行业专业知识和当地市场了解与Bio - Techne创新产品组合是推动土耳其及其他地区科学和医学进步的理想搭配 [3]

文章核心观点 BIO - key与Fiber达成合作，BIO - key收购Fiber持有的Boumarang股份，双方结合各自专长，旨在食品科技领域提升安全、效率并推动创新发展 [1][2][3] 合作交易情况 - BIO - key与专注全球食品安全等业务的Fiber达成协议，BIO - key以59.5万股（占已发行和流通股19%）换得Fiber持有的Boumarang 500万股普通股，该交易使BIO - key资产净额增加500万美元 [1] 双方业务专长 - BIO - key是身份和访问管理（IAM）解决方案提供商，其PortalGuard® IAM平台提供多因素认证，支持全球超3500万用户无电话、无令牌、无密码访问 [1][2] - Fiber是食品科技收购公司，专注批发食品分销和面向消费者的零售产品组合建设，致力于利用创新提升和扩展食品服务解决方案 [9] 合作目标与意义 - 双方旨在解决食品科技领域安全访问和数据保护问题，为食品服务场所设定安全、便捷、无缝访问新标准 [3] 合作带来的战略机遇 - 部署无电话和无密码生物识别认证可加快员工访问速度，提高学校和大学食堂等食品服务环境的效率 [4] - BIO - key的托管或本地部署选项使Fiber能根据各地点需求实施IAM解决方案，确保随着Fiber在食品科技和分销领域拓展业务时可无缝扩展 [5] - 结合最新网络安全技术和食品科技解决方案，推动双方创新卓越，为食品服务技术的安全和效率树立标杆 [6] 各方表态 - BIO - key董事长兼首席执行官表示与Fiber合作是向关键行业提供安全易用IAM解决方案使命的重要里程碑，很高兴将技术带入食品服务领域 [7] - Fiber执行主席称BIO - key的解决方案在安全便捷访问方面有独特优势，很高兴将其技术融入业务，该合作符合创新变革食品科技行业的使命 [7] 相关公司介绍 - Boumarang是先进人工智能无人机开发商，应用于物流、安全和环境监测等领域，注重创新和可持续性，旨在重新定义无人机技术以满足行业和国防不断变化的需求 [10]

MINNEAPOLIS, Nov. 27, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Citi 2024 Global Healthcare Conference on Wednesday, December 4, 2024, at 3:15 p.m. EST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.About Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences ...

MINNEAPOLIS, Nov. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced a partnership with Leader Life Sciences. Under the agreement, Leader Life Sciences becomes a distributor of Bio-Techne's portfolio across the Gulf Cooperation Council (GCC) countries, which include Bahrain, Oman, Qatar, Saudi Arabia, and United Arab Emirates.Founded in 2020, Lead ...

MINNEAPOLIS, Nov. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership with ALZpath, Inc to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's disease. The collaboration leverages Bio-Techne's Ella™ fully automated, multiplexing immunoassay platform and ALZpath's proprietary pTau217 antibody to provide the Simple Plex Human Phospho-Tau (T217) ALZpath Assay. ALZpath The ALZpath pTau217 (phosphorylated Tau2 ...